Stratec SE (FRA:SBS)
22.95
-0.05 (-0.22%)
Last updated: Apr 17, 2025
Stratec SE Company Description
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.
The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE
Country | Germany |
Founded | 2018 |
Industry | Laboratory Analytical Instruments |
Employees | 1,480 |
CEO | Marcus Wolfinger |
Contact Details
Address: Gewerbestrasse 37 Birkenfeld, 75217 Germany | |
Phone | 49 7082 7916 0 |
Website | stratec.com |
Stock Details
Ticker Symbol | SBS |
Exchange | Frankfurt Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Marcus Wolfinger | Chief Executive Officer |
Jan Keppeler | Head of Investor Relations |